- More than two dozen state prosecutors send a letter to the FDA asking the agency to reconsider its approval of the new Zogenix (ZGNX +3%) painkiller Zohydro, saying the narcotic pill could add to the national epidemic of prescription drug abuse.
- The FDA approved Zohydro in October, making it the first single-ingredient hydrocodone drug ever cleared for U.S. patients; the pill uses an extended release formulation reportedly 5x-10x more potent than currently available hydrocodone combination pills such as Vicodin.
- ZGNX has said it is working on a version of the drug that is more difficult to abuse.
States ask FDA to reconsider approval of Zogenix painkiller
Dec 12 2013, 14:14 ET